WeedMD Inc. (TSX-V:WMD) is pleased to announce it has officially begun registering patients and fulfilling orders through its online store. The WeedMD team has passionately worked towards this goal for the past three years, and looks forward to meeting the rapidly growing demand for medical cannabis. Starting pre-registration in May, the Company was fortunate enough to develop a wait list of over 1,000 patients, and plans to leverage its clinic relationships to further accelerate enrollment.

“We are extremely excited to finally open our doors to patients and begin offering access to our diverse selection of medical cannabis,” said Bruce Dawson-Scully, CEO of WeedMD. “This represents a major milestone for our Company and is only just the beginning of what we plan to achieve.”

The number of medical patients in Canada is fast approaching 200,000 – a clear demonstration of society’s faith and demand for a more natural alternative to traditional pharmaceuticals. WeedMD is keenly aware of this demand and looks forward to producing consistently high quality lab tested product to meet the needs and expectations of patients across the country.

In anticipation of beginning sales, WeedMD has produced a sizeable inventory of well over 300kg of dried product that is in its vault and ready for sale. The Company’s product offerings represent a variety of strains with varying levels of CBD and THC to address the diverse needs of medical patients in Canada. WeedMD’s line of products can be accessed online at www.weedmd.com.

WeedMD also received its license to sell cannabis plants to patients registered for home grow under the Access to Cannabis for Medical Purposes Regulations and anticipates beginning sales of cannabis starting materials within the coming week.

For more information, access our website here and our investor presentation here.

About WeedMD Inc.

WeedMD Inc. is a licensed producer of medical cannabis pursuant to the Access to Cannabis for Medical Purposes Regulations (ACMPR). WeedMD operates a 26,000 square foot, scalable production facility in Aylmer, Ontario with over four acres of property for future expansion. WeedMD is focused on providing consistent, quality medicine to the long-term care and assisted living markets in Canada through its comprehensive platform developed exclusively for that industry. WeedMD is dedicated to educating healthcare practitioners and furthering public understanding of the role medical cannabis can play as a viable alternative to prescription medication in relieving a variety of chronic medical conditions and illnesses.

Follow WeedMD On:
Facebook: https://www.facebook.com/weedmd/
LinkedIn: https://www.linkedin.com/company-beta/5020743/
Twitter: https://twitter.com/WeedMD
Instagram: https://www.instagram.com/weedmd/

For further information, please contact:

WeedMD Inc.

Keith Merker, Chief Financial Officer
Tel: 519-765-2440 Ext. 222
Email: investor@weedmd.com

To learn more, visit us at www.weedmd.com

Forward-Looking Information

This press release contains forward-looking information based on current expectations. Statements about the date of trading of the Company’s common shares on the Exchange and final regulatory approvals, among others, are forward-looking information. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. The Company assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law.


NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE

Read more at http://www.stockhouse.com/news/press-releases/2017/05/31/weedmd-officially-opens-patient-registration-and-starts-sales-of-medical#uJbuZY2R563bW9lp.99
 
 Click here to connect with WeedMD Inc. (TSXV:WMD)to receive an Investor Presentation.

Source: www.stockhouse.com

Trulieve Cannabis Corp. (“Trulieve” or the “Company”) (CSE: TRUL) (OTCQX: TCNNF), a leading and top-performing cannabis company in the United States today announced the appointment of Marcum LLP (“Marcum”) as its independent registered public accounting firm, effective July 5, 2021 . Marcum was appointed following the resignation of MNP LLP (“MNP”) as the Company’s independent registered public accounting firm effective July 5, 2021 .

“We would like to thank MNP for their guidance and expertise over the past two years and we look forward to working with Marcum as the Company’s new independent registered public accounting firm,” stated Chief Financial Officer, Alex D’Amico.

Keep reading... Show less

Cannabis-infused beverages are not a new product concept, but this summer Canadian drink makers hope consumers will discover them for the first time.

Recreational cannabis beverages have beguiled Canadian producers through different avenues, and many continue to make investments. The promise of these drinks lies in the potential of a more welcoming option for new consumers who may be out of their depth with rolled-up dried flower.

Keep reading... Show less

In the news release, BioHarvest Sciences Inc.‘s First Cannabis Cell Reservoir Produces Ongoing Flowering Stage Cannabinoid Cells For 2 Years, issued 07-Jul-2021 by BioHarvest Sciences Inc. over PR Newswire, we are advised by the company that an incorrect version of the release was issued inadvertently. The complete, corrected release follows:

BioHarvest Sciences Inc.‘s First Cannabis Cell Reservoir Produces Ongoing Flowering Stage Cannabinoid Cells For 2 Years

Keep reading... Show less

Trulieve is the first medical cannabis operator to start planting in the state

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today that it commenced operations in West Virginia . The Company has begun cultivation at their 100,000 square foot size facility in Huntington, West Virginia .

Keep reading... Show less

– The Company demonstrates the efficiency and reliability of its BioFarming technology by reducing production cycle time for Cannabis from 14-23 weeks to 3-4 weeks.

– The Company’s BioFarming technology will allow the Company to harvest 13-17 cycles per year versus 2-4 cycles per year for conventional Cannabis agriculture.

Keep reading... Show less